Literature DB >> 22700982

Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells.

Hong Kyeung Kim1, Chae Won Kim, Mai-Tram Vo, Hyun Hee Lee, Ji Young Lee, Nal Ae Yoon, Chae Yeong Lee, Chang Hoon Moon, Young Joo Min, Jeong Woo Park, Wha Ja Cho.   

Abstract

The proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is an oncogenic serine/threonine kinase that is up-regulated in several human cancers, facilitates cell cycle progression, and suppresses apoptosis. Previously, it has been reported that the Pim-1 3'-UTR plays important roles in the regulation of Pim-1 mRNA stability. However, the mechanisms explaining how Pim-1 mRNA stability is determined by its 3'-UTR are not well known. Here, we demonstrate that tristetraprolin (TTP) plays a critical role in the regulation of Pim-1 mRNA stability. Our results show that the level of Pim-1 expression is inversely correlated with TTP expression in human cancer cells. Pim-1 mRNA contains two AU-rich elements (ARE1 and ARE2) in the 3'-UTR. TTP bound to ARE2 and enhanced the decay of Pim-1 mRNA. Overexpression of TTP decreased Pim-1 expression and p21 and p27 phosphorylation and inhibited cell growth. Overexpression of Pim-1 cDNA without the 3'-UTR attenuated the inhibitory effects of TTP on p21 phosphorylation and cell growth. In addition, inhibition of p21 by siRNA attenuated the inhibitory effect of TTP on cell growth. Our results suggest that TTP post-transcriptionally down-regulates Pim-1 expression and that the overexpression of TTP may contribute to tumor suppression in part by down-regulating Pim-1 expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700982      PMCID: PMC3436505          DOI: 10.1074/jbc.M112.376483

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase.

Authors:  I Wayne Cheney; Shunqi Yan; Todd Appleby; Heli Walker; Todd Vo; Nanhua Yao; Robert Hamatake; Zhi Hong; Jim Z Wu
Journal:  Bioorg Med Chem Lett       Date:  2007-01-04       Impact factor: 2.823

2.  Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.

Authors:  Myriam Adam; Vanda Pogacic; Marina Bendit; Richard Chappuis; Martijn C Nawijn; Justus Duyster; Casey J Fox; Craig B Thompson; Jan Cools; Juerg Schwaller
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

3.  PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.

Authors:  Xiu Feng Hu; Jie Li; Scott Vandervalk; Zeping Wang; Nancy S Magnuson; Pei Xiang Xing
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

4.  Pim-1 kinase-dependent phosphorylation of p21Cip1/WAF1 regulates its stability and cellular localization in H1299 cells.

Authors:  Yandong Zhang; Zeping Wang; Nancy S Magnuson
Journal:  Mol Cancer Res       Date:  2007-09       Impact factor: 5.852

5.  Up-regulation of a serine-threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma.

Authors:  W-F Chiang; C-Y Yen; C-N Lin; G-A Liaw; C-T Chiu; Y-J Hsia; S-Y Liu
Journal:  Int J Oral Maxillofac Surg       Date:  2006-03-20       Impact factor: 2.789

6.  Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.

Authors:  Daisuke Morishita; Ryohei Katayama; Kazuhisa Sekimizu; Takashi Tsuruo; Naoya Fujita
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

7.  The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.

Authors:  Lisa E Young; Sandhya Sanduja; Kristi Bemis-Standoli; Edsel A Pena; Robert L Price; Dan A Dixon
Journal:  Gastroenterology       Date:  2009-01-15       Impact factor: 22.682

8.  Pim kinase-dependent inhibition of c-Myc degradation.

Authors:  Y Zhang; Z Wang; X Li; N S Magnuson
Journal:  Oncogene       Date:  2008-04-28       Impact factor: 9.867

9.  PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.

Authors:  Alessio Zippo; Alessandra De Robertis; Riccardo Serafini; Salvatore Oliviero
Journal:  Nat Cell Biol       Date:  2007-07-22       Impact factor: 28.824

Review 10.  Potential roles for the PIM1 kinase in human cancer - a molecular and therapeutic appraisal.

Authors:  Nilesh Shah; Brendan Pang; Khay-Guan Yeoh; Shannon Thorn; Chien Shing Chen; Michael B Lilly; Manuel Salto-Tellez
Journal:  Eur J Cancer       Date:  2008-08-18       Impact factor: 9.162

View more
  14 in total

1.  RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response.

Authors:  Sarah E Brennan-Laun; Xiao-Ling Li; Heather J Ezelle; Thiagarajan Venkataraman; Perry J Blackshear; Gerald M Wilson; Bret A Hassel
Journal:  J Biol Chem       Date:  2014-10-09       Impact factor: 5.157

2.  The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.

Authors:  Kumar Saurabh; Michael T Scherzer; Parag P Shah; Alice S Mims; William W Lockwood; Andrew S Kraft; Levi J Beverly
Journal:  Oncotarget       Date:  2014-09-30

3.  Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.

Authors:  Zi-Ran Wei; Chao Liang; Dan Feng; Ya-Jun Cheng; Wei-Min Wang; De-Jun Yang; Yue-Xiang Wang; Qing-Ping Cai
Journal:  Oncotarget       Date:  2016-04-05

4.  ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest.

Authors:  Aya Noguchi; Shungo Adachi; Naoto Yokota; Tomohisa Hatta; Tohru Natsume; Hiroyuki Kawahara
Journal:  Biol Open       Date:  2018-03-12       Impact factor: 2.422

5.  PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.

Authors:  Chune Ren; Tingting Yang; Pengyun Qiao; Li Wang; Xue Han; Shijun Lv; Yonghong Sun; Zhijun Liu; Yu Du; Zhenhai Yu
Journal:  Mol Oncol       Date:  2018-04-14       Impact factor: 6.603

6.  miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer.

Authors:  Wijdan Al-Ahmadi; Maha Al-Ghamdi; Norah Al-Souhibani; Khalid S A Khabar
Journal:  J Pathol       Date:  2013-03-21       Impact factor: 7.996

7.  Resveratrol Induces Glioma Cell Apoptosis through Activation of Tristetraprolin.

Authors:  Jinhyun Ryu; Nal Ae Yoon; Hyemin Seong; Joo Yeon Jeong; Seokmin Kang; Nammi Park; Jungil Choi; Dong Hoon Lee; Gu Seob Roh; Hyun Joon Kim; Gyeong Jae Cho; Wan Sung Choi; Jae-Yong Park; Jeong Woo Park; Sang Soo Kang
Journal:  Mol Cells       Date:  2015-11-04       Impact factor: 5.034

8.  Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.

Authors:  Indira Pandiri; Yingqing Chen; Yeonsoo Joe; Hyo Jeong Kim; Jeongmin Park; Hun Taeg Chung; Jeong Woo Park
Journal:  Breast Cancer Res Treat       Date:  2016-03-08       Impact factor: 4.872

Review 9.  Hallmarks of cancer and AU-rich elements.

Authors:  Khalid S A Khabar
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-06-01       Impact factor: 9.957

Review 10.  The Tristetraprolin Family of RNA-Binding Proteins in Cancer: Progress and Future Prospects.

Authors:  Yogesh Saini; Jian Chen; Sonika Patial
Journal:  Cancers (Basel)       Date:  2020-06-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.